0001127602-22-026643.txt : 20221201 0001127602-22-026643.hdr.sgml : 20221201 20221201172320 ACCESSION NUMBER: 0001127602-22-026643 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221129 FILED AS OF DATE: 20221201 DATE AS OF CHANGE: 20221201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chaguturu Sreekanth K CENTRAL INDEX KEY: 0001928726 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 221439693 MAIL ADDRESS: STREET 1: ONE CVS DRIVE CITY: WOONSOCKET STATE: RI ZIP: 02895 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-11-29 0000064803 CVS HEALTH Corp CVS 0001928726 Chaguturu Sreekanth K ONE CVS DRIVE WOONSOCKET RI 02895 1 EVP and Chief Medical Officer Common Stock 2022-11-29 4 F 0 442 100.88 D 2896.7803 D Common Stock (RSU) 354 D Common Stock (RSU) 2154 D Common Stock (RSU) 1258 D Common Stock (RSU) 2085 D Common Stock (RSU) 2776 D Common Stock (RSU) 6182 D Common Stock (RSU) 12735 D Stock Option 75.27 2020-11-29 2029-11-29 Common Stock 4956 4956 D Stock Option 58.34 2021-04-01 2030-04-01 Common Stock 9579 9579 D Stock Option 74.30 2022-04-01 2031-04-01 Common Stock 9502 9502 D Stock Option 101.09 2023-04-01 2032-04-01 Common Stock 12993 12993 D Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Consists of remaining RSUs awarded pursuant to the Issuer's Performance-Based Restricted Stock Plan, a sub-plan under its 2017 Incentive Compensation Plan. Restrictions on remaining RSUs lapse on 2/28/2023. Consists of remaining RSUs awarded pursuant to the Issuer's 2017 Incentive Compensation Plan. Restrictions on the remaining RSUs lapse in two equal installments beginning 4/1/2023. Consists of remaining RSUs awarded pursuant to the Issuer's 2017 Incentive Compensation Plan. Restrictions on the remaining RSUs lapse in two equal installments beginning 4/1/2023. Consists of remaining RSUs awarded pursuant to the Issuer's Performance-Based Restricted Stock Plan, a sub-plan under its 2017 Incentive Compensation Plan. Restrictions on remaining RSUs lapse in two equal installments beginning 2/26/2023. Consists of RSUs awarded pursuant to the Issuer's 2017 Incentive Compensation Plan. Restrictions on remaining RSUs lapse in three equal installments beginning 4/1/2023. Consists of remaining RSUs awarded pursuant to the Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments beginning 4/1/2023. Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse on the third anniversary of the grant date. Option became exercisable in four equal annual installments, commencing 11/29/2020. Option became exercisable in four equal annual installments, commencing 4/1/2021. Option became exercisable in four equal annual installments, commencing 4/1/2022. Option becomes exercisable in four equal annual installments, commencing 4/1/2023. /s/ Sreekanth K. Chaguturu 2022-11-30